Stay updated with breaking news from Samsung Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Samsung Biologics will participate in the 2024 Bio International Convention, the largest biopharmaceutical exhibition in the industry, to showcase its contract-based drug manufacturing and development capabilities, the company said Monday.
Investegate announcements from Transactions with Affiliated Companies
Samsung Biologics, the biotech arm of Korea's Samsung Group, said Wednesday its net profit jumped 26.5 percent on-year in the first quarter thanks to strong sales.
Samsung Biologics, a leading contract development and manufacturing organization, announced Wednesday that the company’s earnings in the first quarter this year hit an all-time high. In the January-March period, Samsung Biologics’ sales increased by 31.3 percent on-year to 946.9 billion won ($690 million) from the previous year’s 720.9 billion won. Its operating profit also reached 221.3 billion won...
Samsung Electronics Chair and Samsung Group leader Lee Jae-yong on Friday visited the group’s biotech arm in Incheon, calling on executives and staff members to set higher goals after the unit posted all-time high earnings last year. At Samsung Biologics’ biopharmaceutical campus in the Songdo Industrial Cluster in Incheon, the chair inspected the construction site of its fifth plant with a capacity of 18...